Muscle News and Research

RSS

Early bone molecular changes signal osteoarthritis progression

Osteoarthritis often goes undetected until cartilage damage is advanced, limiting treatment options. A new study shows that molecular changes in subchondral bone occur earlier and can signal disease progression before cartilage loss.

10 Feb 2026

Beta arrestin 1 emerges as key driver of pulmonary hypertension

Researchers have uncovered the pivotal role of a previously overlooked protein in the development of the serious illness.

10 Feb 2026

Childhood cancer survival varies by tumor stage at diagnosis

A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children's cancer has spread at diagnosis in a way that can be compared between countries.

9 Feb 2026

Influenza viruses can directly impair heart function

Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk of a heart attack or other major cardiovascular event.

9 Feb 2026

Study identifies link between gut bacteria and deterioration of the brain in ALS, dementia

A significant discovery by Case Western Reserve University researchers could change how doctors treat two of the most devastating neurodegenerative diseases.

9 Feb 2026

IRF7 reshapes the behavior of vascular smooth muscle cells during atherosclerosis

Atherosclerosis underlies most heart attacks and strokes and is now recognized as a chronic inflammatory disease rather than a simple disorder of cholesterol deposition.

9 Feb 2026

Study reveals how two key proteins contribute to abnormal bone growth after injury

After serious injuries, burns, fractures, or major surgeries, the body normally repairs damaged tissues and restores movement.

9 Feb 2026

Intense exercise proves more effective for panic disorder treatment

Panic attacks are sudden bouts of intense fear without an obvious cause. An estimated 10% of people experience at least one panic attack in their lifetime.

9 Feb 2026

Most statin side effects are not backed by trials

Research indicates that many statin therapy side effects are not supported by evidence, suggesting a need for revised labeling to improve treatment decisions.

9 Feb 2026

Optical tissue monitoring predicts dialysis-related fluid instability

For the millions of people living with end‑stage kidney disease, hemodialysis is more than a medical procedure, it is a thrice‑weekly lifeline that keeps the body's chemistry in balance.

7 Feb 2026

Griffith researchers on the cusp of new vaccine to prevent chikungunya

Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue.

6 Feb 2026

New meta-analysis challenges claims of athletic advantage for transgender women

A meta-analysis of 52 studies reveals insights into body composition and fitness in transgender athletes, challenging assumptions about competitive advantage.

6 Feb 2026

Why “low testosterone” has become a profitable masculinity crisis online

Social media's portrayal of low testosterone transforms masculinity into a marketable issue, linking health interventions to male identity and performance.

6 Feb 2026

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of its Liver.SET™ library of liver-specific synthetic promoters.

5 Feb 2026

Large trials show statins rarely cause reported side effects

Cardiovascular disease results in around 20 million deaths worldwide and causes around a quarter of all deaths in the UK.

5 Feb 2026

Brain network discovery opens new path for Parkinson’s treatment

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 million globally, is characterized by debilitating symptoms such as tremors, movement difficulties, sleep disturbances and cognitive impairments.

4 Feb 2026

Rapid zebrafish model mimics muscle aging and sarcopenia

As people age, muscles naturally lose mass and strength, a condition known as sarcopenia. The decline can make everyday activities harder and increases the risk of falls, disability and early death.

4 Feb 2026

New immunotherapy could replace daily pills after kidney transplantation

A new study offers hope that kidney transplant patients could one day have a monthly treatment instead of multiple pills every day.

3 Feb 2026

Why cardiologist evaluation matters after non-cardiac surgery

Interdisciplinary collaboration with cardiologists in non-cardiac surgery enhances patient outcomes, reducing cardiac event risks and improving survival rates.

3 Feb 2026

Targeted therapy for the less impaired arm improves movement for stroke survivors

Traditional stroke rehabilitation therapy focuses on restoring strength and movement to the more impaired side of the body, but a new randomized clinical trial has revealed that targeted therapy for the less impaired arm significantly improved movement and control for stroke survivors.

2 Feb 2026